SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Genaera Corp

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: DewDiligence_on_SI7/3/2006 5:33:48 PM
   of 96
 
In the recent financing, GENR had to reimburse the placement agents for their out-of-pocket expenses in addition to paying them a standard 6% commission (which brought the effective commission rate to about 8%). This is an unusual provision for a company is that is not in financial distress:

sec.gov

>>
We have also agreed to reimburse the placement agents for out-of-pocket expenses incurred by them in connection with this offering. The maximum commission or discount to be received by any NASD member or independent broker/dealer will not be greater than 8.0% for the sale of any securities pursuant to this registration statement.
<<


What this shows is that GENR has come perilously close to being locked out of any kind of non-toxic financing.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext